210
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients

, , &
Pages 1623-1633 | Accepted 05 Jun 2011, Published online: 22 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now

Articles from other publishers (2)

Barbara E. Stähli, Catherine Gebhard & Jean-Claude Tardif. (2015) Lipid Effects and Cardiovascular Disease Risk Associated with Glucose-Lowering Medications. Current Cardiology Reports 17:7.
Crossref
Suzan M. Mansour, Hala F. Zaki & Ezz-El-Din S. El-Denshary. (2013) Beneficial effects of co-enzyme Q10 and rosiglitazone in fructose-induced metabolic syndrome in rats. Bulletin of Faculty of Pharmacy, Cairo University 51:1, pages 13-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.